Follow The Filings

BBLG Bone Biologics

Bone Biologics earnings company data as of 4:47 AM ET 10/22

  • 0 of 1 EPS beats

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —
FY2026 Q2 14 Aug EPS -0.39 -0.43 Miss
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 5.07
8-K 3.01
DEF 14A
10-Q
424B3
8-K 7.01,9.01
DEFA14A
8-K 8.01
8-K 1.01,3.02,8.01,9.01
DEF 14A
DEFA14A
10-Q
424B5
8-K 8.01,9.01
10-K
8-K 7.01,9.01
10-Q
SCHEDULE 13G/A —
8-K 7.01,9.01
10-Q
SCHEDULE 13G —
424B4
8-K 1.01,8.01,9.01
8-K 8.01,9.01
S-1

Insider forms

Forms 3, 4 and 5 from EDGAR, 2 rows shown

Filed Form Detail Links
4 Period Sep 28, 2026 (4 forms)
4 Period Jan 8, 2026

5 more insider forms

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.